Diagnosis and Treatment of Pityriasis Versicolor: A Review of Current Methods and Research Findings
DOI:
https://doi.org/10.12775/QS.2025.44.62963Keywords
pityriasis versicolor, MalasseziaAbstract
Pityriasis versicolor is a common, mild skin disease caused by a yeast-like fungus from the Malassezia genus. This fungus naturally inhabits the skin of healthy individuals, but under certain conditions, such as increased sebum production or immunocompromised states, it can lead to the formation of scaly patches that are hypo or hyperpigmented, and sometimes they can be discolored. These lesions typically appear on the torso, neck, or shoulders and vary in size. Over time, they may enlarge. Diagnosis involves a physical examination, mycological testing, and examination under a Wood's lamp. Treatment consists of topical or systemic antifungal medications. The condition is recurrent. Personal hygiene plays an important role in prevention.
The article is a comprehensive review of the available scientific literature on the pathogenesis, clinical picture, diagnosis and treatment of pityriasis versicolor.
References
[1] Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Tinea versicolor: an updated review. Drugs Context. 2022;11:2022-9-2. Published 2022 Nov 14. doi:10.7573/dic.2022-9-2
[2] Łabędź N, Navarrete-Dechent C, Kubisiak-Rzepczyk H, Bowszyc-Dmochowska M, Pogorzelska-Antkowiak A, Pietkiewicz P. Pityriasis Versicolor-A Narrative Review on the Diagnosis and Management. Life (Basel). 2023;13(10):2097. Published 2023 Oct 22. doi:10.3390/life13102097
[3] Almalki MK, Alruwaili ZM, Alhammad NS, Alawadi TM, Dajam MS. Tinea Versicolor in a Three-Month Infant: A Case Report and Literature Review. Cureus. 2023;15(6):e40763. Published 2023 Jun 21. doi:10.7759/cureus.40763
[4] Karray M, McKinney WP. Tinea Versicolor. [Updated 2024 Feb 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482500/
[5] Gupta AK, Foley KA. Antifungal Treatment for Pityriasis Versicolor. J Fungi (Basel). 2015;1(1):13-29. Published 2015 Mar 12. doi:10.3390/jof1010013
[6] Saunte DML, Gaitanis G, Hay RJ. Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Front Cell Infect Microbiol. 2020;10:112. Published 2020 Mar 20. doi:10.3389/fcimb.2020.00112
[7] Wissal Chebil, Najoua Haouas, Raja Chaâbane-Banaoues, Latifa Remadi, Najla Chargui, Selim M'rad, Sameh Belgacem, Azer Ben Salah, Hichem Belhadj Ali, Zeineb Chemli, Marwa Lakoudi, Claudia Cafarchia, Hamouda Babba. Epidemiology of Pityriasis versicolor in Tunisia: Clinical features and characterization of Malassezia species, Journal of Medical Mycology,
Volume 32, Issue 2, 2022, 101246, ISSN 1156-5233, https://doi.org/10.1016/j.mycmed.2022.101246
[8] Alvarado Z, Pereira C. Fungal diseases in children and adolescents in a referral centre in Bogota, Colombia, MycosesVolume 61, Issue 8 p. 543-548, Published 2018 Mar 30. https://doi.org/10.1111/myc.12774
[9] Velegraki A, Cafarchia C, Gaitanis G, Iatta R, Boekhout T. Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS Pathog. 2015;11(1):e1004523. Published 2015 Jan 8. doi:10.1371/journal.ppat.1004523
[10] Sparber F, LeibundGut-Landmann S. Host Responses to Malassezia spp. in the Mammalian Skin. Front Immunol. 2017;8:1614. Published 2017 Nov 22. doi:10.3389/fimmu.2017.01614
[11] Später, S., Hipler, UC., Haustein, UF. et al. Bildung von reaktiven Sauerstoffspezies in vitro durch Malassezia-Hefen . Hautarzt 60, 122–127 (2009). https://doi.org/10.1007/s00105-008-1684-y
[12] Kurniadi I, Hendra Wijaya W, Herawan Timotius K. Malassezia virulence factors and their role in dermatological disorders; 2022;31:65-70, doi: 10.15570/actaapa.2022.8
Available from: https://acta-apa.mf.uni-lj.si/journals/acta-dermatovenerol-apa/papers/10.15570/actaapa.2022.8/actaapa.2022.8.pdf
[13] Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Tinea versicolor: an updated review. Drugs Context. 2022;11:2022-9-2. Published 2022 Nov 14. doi:10.7573/dic.2022-9-2
[14] Mathur M, Acharya P, Karki A, Kc N, Shah J. Dermoscopic pattern of pityriasis versicolor. Clin Cosmet Investig Dermatol. 2019;12:303-309. Published 2019 Apr 30. doi:10.2147/CCID.S195166
[15] Anne Han, MD; David A. Calcara, BS; William V. Stoecker, MS, MD; et al, Evoked Scale Sign of Tinea Versicolor, Arch Dermatol. 2009;145(9):1078. September 2009, doi:10.1001/archdermatol.2009.203
[16] Renati S, Cukars A, Bigby M; Pityriasis versicolor, https://doi.org/10.1136/bmj.h1394 (Published 07 April 2015)
[17] Leeming JP, Sansom JE, Burton JL. Susceptibility of Malassezia furfur subgroups to terbinafine. Br J Dermatol. 1997;137(5):764-767.
[18] R.J. HAY, G. MIDGELEY, Short course ketoconazole therapy in pityriasis versicolor, Clinical and Experimental Dermatology, Volume 9, Issue 6, 1 November 1984, Pages 571–573, https://doi.org/10.1111/j.1365-2230.1984.tb00861.x
[19] Pityriasis versicolor with ketoconazole, Nardo Zaias. Available from: https://www.jaad.org/article/S0190-9622(89)80166-5/pdf
[20] Faergemann J, Gupta AK, Al Mofadi A, Abanami A, Shareaah AA, Marynissen G. Efficacy of Itraconazole in the Prophylactic Treatment of Pityriasis (Tinea) Versicolor. Arch Dermatol. 2002;138(1):69–73. doi:10.1001/archderm.138.1.69
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Adrianna Jasiuk, Mateusz Wiekiera , Natalia Madeja, Sylwia Koziej , Martyna Niemczuk , Emilia Kowalczyk

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 341
Number of citations: 0